CROSBY Research – Vincent Medical (1612 HK/BUY): Achieving financial turnaround in FY23

21 Mar 2024 Vincent Medical’s FY23 turnover (VM) amounted to HK$718.0m, representing a YoY increase ...

CROSBY Research – Xiaomi Corporation (1810 HK): Solid 4Q23 core business recovery; launching of new EV will be near-term catalyst

21 Mar 2024 Xiaomi reported 4Q23 results, with its revenue up 10.9% YoY to Rmb73.2bn, ...

CROSBY Research – Xtep International (1368 HK/BUY): Inline FY23 results ; Saucony achieved profitability

19 Mar 2024 Xtep’s FY23 revenue was up by 10.9% YoY to Rmb14,346m, mainly driven ...

CROSBY Research – China Lilang (1234 HK): Expects at least 15% retail sales growth in FY24

19 Mar 2024 The company reported a 14.8% YoY increase in topline to Rmb3,544m in ...

CROSBY Research – Wasion Holdings (3393 HK/BUY): Strong FY23 NP growth on solid revenue growth and GPM improvement

18 Mar 2024 Following the positive profit alert issued in Feb, it is no surprise ...

CROSBY Research – Giordano (709 HK): FY23 NP rose by 29% YoY on higher GPM and operating leverage

18 Mar 2024 FY23 revenue slightly increased by 1.9% YoY to HK$3,873m, mainly supported by ...

CROSBY Research – 361 Degrees (1361 HK/BUY): Solid FY23 results with strong growth from Kids and online segments

14 Mar 2024 FY23 revenue was up 21.0% YoY to Rmb8.4bn, with core brand retail ...

CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 54)

11 Mar 2024 (Bloomberg) Hong Kong’s 10 biggest residential estates saw transactions rise to the ...

CROSBY Research – Concord (182 HK/BUY): Solid FY23 results

08 Mar 2024 CNE’s FY23 revenue was up by 7.8% YoY to Rmb2,589m (excluding the ...

CROSBY Research – JNBY (3306 HK): Net profit increased by 55% YoY on better margins

01 Mar 2024 JNBY announced its FY1H24 interim results, with revenue increased by 26.1% YoY ...

CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 53)

26 Feb 2024 2023 the global economic activities were sluggish. The US Federal Reserve, in ...

CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 52)

06 Feb 2024 Under a so-called “white lists” mechanism, in which residential projects on the ...

CROSBY Research – Vincent Medical (1612 HK/BUY): Turnaround in FY23

02 Feb 2024 Vincent Medical (VM) issued a positive profit alert citing that based on ...

CROSBY Research – Sunny Optical (2382 HK/BUY): FY23 profit warning, expect product mix improvement in FY24

02 Feb 2024 Sunny issued profit warning that net profit may decline 50%-55% YoY in ...

CROSBY Research – China Everbright Greentech (1257 HK/BUY): FY23 results preview

29 Jan 2024 CEG’s 1H23 revenue edged down by 9% YoY to HK$3,820m, and 1H23NP ...

CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 51)

22 Jan 2024 The concept of consumer downgrading – In recent years, a new consumer ...

CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 50)

08 Jan 2024 Economists polled by Bloomberg had forecast that nonfarm payrolls likely increased by ...

CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 49)

11 Dec 2023 Chinese banks are stepping up their lending support for private property enterprises ...

CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 48)

27 Nov 2023 Black Friday e-commerce spending was up by 7.5% YoY, reaching a record ...